Bridgeway Capital Management, LLC Hcw Biologics Inc. Transaction History
Bridgeway Capital Management, LLC
- $4.24 Billion
- Q4 2024
A detailed history of Bridgeway Capital Management, LLC transactions in Hcw Biologics Inc. stock. As of the latest transaction made, Bridgeway Capital Management, LLC holds 34,700 shares of HCWB stock, worth $13,880. This represents 0.0% of its overall portfolio holdings.
Number of Shares
34,700
Previous 84,700
59.03%
Holding current value
$13,880
Previous $45,000
68.89%
% of portfolio
0.0%
Previous 0.0%
Shares
6 transactions
Others Institutions Holding HCWB
# of Institutions
19Shares Held
3.13MCall Options Held
0Put Options Held
0-
Armistice Capital, LLC New York, NY2.02MShares$809,4650.01% of portfolio
-
Avantax Planning Partners, Inc.280KShares$111,8160.0% of portfolio
-
Geode Capital Management, LLC Boston, MA182KShares$72,7820.0% of portfolio
-
High Tower Advisors, LLC Chicago, IL181KShares$72,3240.0% of portfolio
-
Cresset Asset Management, LLC Chicago, IL132KShares$52,7960.0% of portfolio
About HCW Biologics Inc.
- Ticker HCWB
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 35,833,100
- Market Cap $14.3M
- Description
- HCW Biologics Inc., a preclinical stage biopharmaceutical company, focuses on discovering and developing novel immunotherapies for chronic, low-grade inflammation, and age-related diseases. The company's lead products include HCW9218, which is an injectable immunotherapeutic for patients with pancreatic, ovarian, breast, prostate, and colorectal...